1955 Capital — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Nature's Fyndnaturesfynd.comSeries A · Feb 2019 · $33M
The Fynder Group develops a biotechnology platform using extremophile fungi to produce specialty ingredients, biopharmaceutical drugs, and bio-based materials for food, beverage, pharmaceutical, and textile applications.
BiotechFoodTechNew MaterialsChicago, US
Matthew Strongin(Founder)in
Co-investorsBreakthrough Energy VenturesDanone Manifesto VentureLauder PartnersSoftBank Vision Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.